Approximately one in seven women experience postpartum depression (PPD) after giving birth. This goes beyond the typical exhaustion that comes from new parenthood. With PPD, even basic functioning is difficult and, for many, it impacts the budding relationship between mom and baby. But a new sense of hope is on the horizon. Earlier this month, the Food and Drug Administration approved the very first pill specifically made to treat PPD, Zurzuvae (zuranolone). Psychiatrists specializing in maternal mental health are excited about this new advancement, but there are some important facts they want anyone thinking about taking it to know. Related: These Excerpts From Teresa Wong's Graphic Memoir
Hence then, the article about the fda approved the first pill for postpartum depression here s how it s different from other antidepressants was published today ( ) and is available onParade ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The FDA Approved the First Pill for Postpartum Depression—Here’s How It’s Different From Other Antidepressants )